Patents by Inventor Christina Anderlind

Christina Anderlind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NASAL EPITHELIUM GENE EXPRESSION SIGNATURE AND CLASSIFIER FOR THE PREDICTION OF LUNG CANCER
    Publication number: 20210381062
    Abstract: This application provides assays and methods for diagnosis and prognosis of lung cancer using expression analysis of one or more genes from a biological sample comprising nasal epithelial cells. The assays and methods are non-invasive and accurately detect the presence or absence of lung cancer relative to, for example, more invasive techniques, such as bronchoscopy. Similarly, the assays and methods described provide non-invasive ways of accurately identifying the smoking history of a subject.
    Type: Application
    Filed: August 9, 2021
    Publication date: December 9, 2021
    Inventors: Avrum Spira, Marc E. Lenburg, Joseph Perez-Rogers, Christina Anderlind
  • NASAL EPITHELIUM GENE EXPRESSION SIGNATURE AND CLASSIFIER FOR THE PREDICTION OF LUNG CANCER
    Publication number: 20190292600
    Abstract: Disclosed herein are assays and methods for diagnosis and prognosis of lung cancer using expression analysis of one or more genes from a biological sample comprising nasal epithelial cells. The assays and methods of the invention provide non-invasive means of accurately detecting the presence or absence of lung cancer relative to, for example, more invasive techniques, such as bronchoscopy. Similarly, in certain aspects, the assays and methods disclosed herein provide non-invasive means of accurately identifying the smoking history of a subject.
    Type: Application
    Filed: May 12, 2017
    Publication date: September 26, 2019
    Inventors: Avrum Spira, Marc Lenburg, Joseph Perez-Rogers, Christina Anderlind